- Home
- VCEL vs MNTSW Comparison
VCEL vs MNTSW Comparison
Compare VCEL & MNTSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCEL
- MNTSW
- Stock Information
- Founded
- VCEL 1989
- MNTSW N/A
- Country
- VCEL United States
- MNTSW United States
- Employees
- VCEL N/A
- MNTSW 123
- Industry
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- MNTSW Military/Government/Technical
- Sector
- VCEL Health Care
- MNTSW Industrials
- Exchange
- VCEL Nasdaq
- MNTSW Nasdaq
- Market Cap
- VCEL 2.1B
- MNTSW N/A
- IPO Year
- VCEL 1997
- MNTSW 2019
- Fundamental
- Price
- VCEL $31.85
- MNTSW $0.02
- Analyst Decision
- VCEL Strong Buy
- MNTSW
- Analyst Count
- VCEL 6
- MNTSW 0
- Target Price
- VCEL $60.60
- MNTSW N/A
- AVG Volume (30 Days)
- VCEL 823.8K
- MNTSW N/A
- Earning Date
- VCEL 11-06-2025
- MNTSW N/A
- Dividend Yield
- VCEL N/A
- MNTSW N/A
- EPS Growth
- VCEL 2045.40
- MNTSW N/A
- EPS
- VCEL 0.13
- MNTSW N/A
- Revenue
- VCEL $249,119,000.00
- MNTSW N/A
- Revenue This Year
- VCEL $18.35
- MNTSW N/A
- Revenue Next Year
- VCEL $22.47
- MNTSW N/A
- P/E Ratio
- VCEL $236.01
- MNTSW N/A
- Revenue Growth
- VCEL 16.13
- MNTSW N/A
- 52 Week Low
- VCEL $29.93
- MNTSW N/A
- 52 Week High
- VCEL $63.00
- MNTSW N/A
- Technical
- Relative Strength Index (RSI)
- VCEL 42.72
- MNTSW N/A
- Support Level
- VCEL $29.93
- MNTSW N/A
- Resistance Level
- VCEL $33.25
- MNTSW N/A
- Average True Range (ATR)
- VCEL 1.75
- MNTSW 0.00
- MACD
- VCEL -0.14
- MNTSW 0.00
- Stochastic Oscillator
- VCEL 27.91
- MNTSW 0.00
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.
About MNTSW Momentus Inc. Warrant
Momentus Inc offers in-space infrastructure services by building transfer and service vehicles that carry satellites and hosted payloads between orbits in space. It is a provider of three critical functions, in the new space economy: Space Transportation, Satellite as a Service, and In-Orbit Servicing.